National strategy needed for catastrophic drugs
There’s a growing controversy over the coverage of very high cost drugs used to treat cancer and other catastrophic diseases in Canada. Most recently, Cancer Care Ontario(CCO)has proposed to change the way Ontario hospitals fund certain cancer drugs administered intravenously(IV)to patients in hospital. The CCO is taking the position that hospitals are not bound by […]
- May 30, 2007 September 13, 2019
- 00:00